Aurobindo Pharma gets USFDA nod for Tofacitinib tablets

Aurobindo Pharma gets USFDA nod for Tofacitinib tablets – a generic version of Xeljanz used to treat rheumatoid arthritis. The approval allows the company to launch the 5 mg tablet in the US market, expanding its portfolio. This adds to Aurobindo’s growing list of ~400 ANDA approvals.
📊 STOCKS: AUROPHARMA | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #USFDA